Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	89.07	55.29	44.7	120.39	198.05	19.24
Cash & Short-Term Investments	89.07	55.29	44.7	120.39	198.05	19.24
Cash Growth	162.13%	23.68%	-62.87%	-39.22%	929.49%	-60.61%
Other Receivables	2	2	-	-	-	-
Receivables	2	2	-	-	-	-
Prepaid Expenses	2.13	2.94	3.42	4.11	4.46	1.35
Total Current Assets	93.2	60.23	48.13	124.5	202.52	20.59
Property, Plant & Equipment	8.73	9.06	11.2	13.06	13.9	14.06
Other Long-Term Assets	1.79	1.78	1.6	1.61	1.64	1.66
Total Assets	103.72	71.08	60.93	139.17	218.06	36.32
Accounts Payable	2.28	2.57	1.05	3.13	3.14	5.44
Accrued Expenses	3.88	9.98	10.5	10.33	8.75	13.73
Current Portion of Long-Term Debt	-	-	3.32	6.67	-	2.33
Current Portion of Leases	1.23	1.19	1.1	1	0.88	0.65
Current Unearned Revenue	40.25	13.52	-	-	-	-
Total Current Liabilities	47.64	27.26	15.96	21.12	12.78	22.16
Long-Term Debt	-	-	-	3.17	9.63	7.81
Long-Term Leases	6.64	6.95	8.14	9.23	10.23	11.1
Long-Term Unearned Revenue	38.74	19.26	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.54
Total Liabilities	93.02	53.48	24.1	33.52	32.63	41.6
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-In Capital	407.71	401.35	362.34	354.75	346.31	1.8
Retained Earnings	-397.02	-383.75	-325.51	-249.11	-160.89	-85.09
Total Common Equity	10.7	17.6	36.83	105.65	185.43	-83.29
Shareholders' Equity	10.7	17.6	36.83	105.65	185.43	-5.29
Total Liabilities & Equity	103.72	71.08	60.93	139.17	218.06	36.32
Total Debt	7.86	8.14	12.55	20.07	20.74	21.89
Net Cash (Debt)	81.21	47.15	32.15	100.32	177.32	-2.65
Net Cash Growth	224.73%	46.64%	-67.95%	-43.42%	-	-
Net Cash Per Share	1.25	0.88	1.17	3.66	31.63	-5.06
Filing Date Shares Outstanding	51.78	51.77	34.47	27.43	27.36	0.81
Total Common Shares Outstanding	51.78	45.76	27.61	27.43	27.36	0.81
Working Capital	45.56	32.97	32.17	103.38	189.74	-1.57
Book Value Per Share	0.21	0.38	1.33	3.85	6.78	-103.39
Tangible Book Value	10.7	17.6	36.83	105.65	185.43	-83.29
Tangible Book Value Per Share	0.21	0.38	1.33	3.85	6.78	-103.39
Machinery	6.91	6.78	6.68	6.45	4.67	3.64
Construction In Progress	-	-	-	0.1	0.54	-
Leasehold Improvements	5.12	5.12	5.12	5.12	5.12	5.09

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q